Cargando…
Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives
BACKGROUND: Chemotherapy is a first-line treatment for advanced and metastatic bladder cancer, but the unsatisfactory objective response rate to this treatment yields poor 5-year patient survival. Only PD-1/PD-L1-based immune checkpoint inhibitors, FGFR3 inhibitors and antibody-drug conjugates are a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263750/ https://www.ncbi.nlm.nih.gov/pubmed/35777908 http://dx.doi.org/10.1016/j.jare.2021.11.010 |